Texas Instruments Incorporated

(NASDAQ Global Select)
Back to all articles
Somewhat Bullish +45

Texas Instruments jumps 3.7% as chip-cycle recovery optimism and fresh analyst target hikes lift sentiment - Quiver Quantitative

AI-generated analysis

πŸ“ˆ Texas Instruments shares jumped 3.7% on March 24, 2026, fueled by chip-cycle recovery optimism and fresh analyst upgrades.

πŸ’° The company guided for Q1 revenue of $4.32B-$4.68B and EPS of $1.22-$1.48, signaling stabilizing demand.

🏭 Analysts cite moderating capital intensity and expanding free-cash-flow potential following a multi-year capacity build.

πŸ’» Data-center-related demand is providing incremental support to the broader analog portfolio.

πŸ“‰ Insider selling remains heavy with 12 sales vs. 0 purchases over the last six months led by CFO Rafael R Lizardi.

🏦 Major institutions like UBS Asset Management and Bank of America significantly reduced holdings in Q4 2025.

πŸ” Analyst consensus shows a median price target of $225.0 with targets ranging from $175 to $260.

⭐ Recent analyst ratings include multiple 'Buy' and 'Overweight' designations from firms like JP Morgan and Goldman Sachs.

Bullish Signals
  • Texas Instruments is benefiting from a perceived recovery in the analog semiconductor cycle, leading to a 3.7% stock price increase.
  • The company's March-quarter guidance of $4.32B-$4.68B revenue and $1.22-$1.48 EPS suggests that sequential growth is returning after a downturn.
  • Analysts view the current environment as one where capital intensity is moderating, which should expand free-cash-flow potential for the company.
  • Specific demand strength in the data-center sector is acting as an incremental support driver for Texas Instruments' analog portfolio.
  • Multiple major Wall Street firms, including JP Morgan, Rosenblatt, and Goldman Sachs, have issued 'Buy' or 'Overweight' ratings recently.
Risk Factors
  • Insider trading data shows a complete lack of buying activity over the past six months, with executives like CFO Rafael R Lizardi selling $15.9M worth of shares.
  • Institutional investors have been net sellers in Q4 2025, with UBS Asset Management reducing its position by 77.1% and Bank of America by 39.1%.
  • Analyst price targets vary significantly, with Goldman Sachs setting a target of $175 while others like UBS set targets as high as $260, indicating divergent views on valuation.
Full Analysis
Texas Instruments (TXN) shares rose 3.7% driven by optimism regarding an analog semiconductor cycle recovery, positive quarterly guidance, and a series of upgraded analyst price targets. The stock benefited from broader investor positioning in high-quality chip names as demand trends for industrial and data-center applications appear to be stabilizing. The company provided specific financial outlooks for the March quarter, projecting revenue between $4.32 billion and $4.68 billion with earnings per share (EPS) ranging from $1.22 to $1.48. Investors interpret these figures as evidence that sequential growth is returning to the sector following a period of heavy capital investment. Wall Street analysts have highlighted expanding free-cash-flow potential as capital intensity moderates post-capacity build. Specific data-center-related demand is noted as an incremental support for TXN's analog portfolio, reinforcing the bullish sentiment despite mixed insider and institutional trading activity in recent quarters.